Author:
Olson Amy L.,Maher Toby M.,Acciai Valentina,Mounir Baher,Quaresma Manuel,Zouad-Lejour Leila,Wells Christopher D.,De Loureiro Lou
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference12 articles.
1. Buzan MTA, Pop CM. State of the art in the diagnosis and management of interstitial lung disease. Clujul Med. 2015;88(2):116–23.
2. Valeyre D, Duchemann B, Nunes H, Uzunhan Y, Annesi-Maesano I. Interstitial lung diseases. In: Annesi-Maesano I, Lundbäck B, Viegi G, editors. Respiratory epidemiology. Lausanne: European Respiratory Society; 2014. p. 79.
3. Flaherty KR, Brown KK, Wells AU, et al. Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Respir Res. 2017;4(1):e000212.
4. Wells AU, Brown KK, Flaherty KR, Kolb M, Thannickal VJ, IPF Consensus Working Group. What's in a name? That which we call IPF, by any other name would act the same. Eur Respir J. 2018;51(5):1800692.
5. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795–806.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献